Plant-derived elastin binding protein ligands and methods of using the same
The present invention describes novel plant derived elastin-like peptides and peptidomimetics that may serve as functional ligands for elastin receptors and stimulate elastogenesis. The novel plant derived peptides provide an alternative (non-animal derived) source of GXXPG (SEQ ID NO. 2) containing peptides. The present invention also describes therapeutic compositions containing novel plant derived peptides or peptidomimetics useful in stimulating elastogenensis and capillary dilatation. The therapeutic compositions of the present invention that comprise novel plant derived peptides or peptidomimetics may be combined with other therapeutic agents.
1. A synthetic peptide comprising a sequence selected from the group consisting of VGLMPG (SEQ ID NO. 19), VGASPG (SEQ ID NO. 20), IGLMPG (SEQ ID NO. 21), IGASPG (SEQ ID NO. 22), and combinations thereof.
2. The synthetic peptide of claim 1 , wherein the peptide is acetylated at N-terminus.
3. A composition comprising a synthetic peptide comprising a sequence selected from the group consisting of VGLMPG (SEQ ID NO. 19), VGASPG (SEQ ID NO. 20), IGLMPG (SEQ ID NO. 21), IGASPG (SEQ ID NO. 22), and combinations thereof.
4. The composition of claim 3 , wherein the synthetic peptide is acetylated at N-terminus.
5. The composition of claim 3 , wherein the composition is a solution, a cream, an emulsion, a gel, a solid, or an aerosol.
6. The composition of claim 3 , further comprising a manganese compound, a trivalent iron compound, a sodium compound, a copper compound, an antioxidant, an additive, an excipient, or combinations thereof.
7. The composition of claim 3 , wherein the composition is a topical composition.
8. A method of improving an appearance of a skin in a subject comprising administering an effective amount of a composition comprising a synthetic peptide comprising a sequence selected from the group consisting of VGLMPG (SEQ ID NO. 19), VGASPG (SEQ ID NO. 20), IGLMPG (SEQ ID NO. 21), IGASPG (SEQ ID NO. 22), and combinations thereof.
9. The method of claim 8 , wherein the synthetic peptide is acetylated at N-terminus.
10. The method of claim 8 , wherein the composition provides an appearance of increased elastogenesis in a tissue.
11. The method of claim 8 , wherein the composition stimulates proliferation and migration of dermal fibroblasts into an area of skin.
12. The method of claim 8 , wherein the composition increases elastogenesis.
13. The method of claim 8 , wherein the administering includes at least one of topical application and application via a transdermal patch.
14. The method of claim 8 , wherein the composition further comprises a manganese compound, a trivalent iron compound, a sodium compound, a copper compound, an antioxidant, an additive, an excipient, or combinations thereof.
15. A method of treating facial lines and wrinkles in a subject comprising administering an effective amount of a composition comprising a synthetic peptide comprising a sequence selected from the group consisting of VGLMPG (SEQ ID NO. 19), VGASPG (SEQ ID NO. 20), IGLMPG (SEQ ID NO. 21), IGASPG (SEQ ID NO. 22), and combinations thereof.
16. The method of claim 15 , wherein the synthetic peptide is acetylated at N-terminus.
17. The method of claim 15 , wherein the administering includes at least one of topical application and application via a transdermal patch.
18. The method of claim 15 , wherein the composition further comprises a manganese compound, a trivalent iron compound, a sodium compound, a copper compound, an antioxidant, an additive, an excipient, or combinations thereof.